This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Aug;8(4):vii-viii.

doi: 10.1089/oli.1.1998.8.vii.

Vitravene--another piece in the mosaic

PMID: 9743463
DOI: 10.1089/oli.1.1998.8.vii

Editorial

Vitravene--another piece in the mosaic

S T Crooke. Antisense Nucleic Acid Drug Dev. 1998 Aug.

. 1998 Aug;8(4):vii-viii.

doi: 10.1089/oli.1.1998.8.vii.

Author

PMID: 9743463
DOI: 10.1089/oli.1.1998.8.vii

No abstract available

PubMed Disclaimer

Similar articles

New CMV retinitis drug approved.
[No authors listed] [No authors listed] Body Posit. 1998 Oct;11(10):10. Body Posit. 1998. PMID: 11365907
Fomivirsen approved for CMV retinitis.
Roehr B. Roehr B. J Int Assoc Physicians AIDS Care. 1998 Oct;4(10):14-6. J Int Assoc Physicians AIDS Care. 1998. PMID: 11365956
Fomiversen sodium approved to treat CMV retinitis.
Piascik P. Piascik P. J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):84-5. doi: 10.1016/s1086-5802(16)30428-4. J Am Pharm Assoc (Wash). 1999. PMID: 9990192 No abstract available.
Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr RM. Orr RM. Curr Opin Mol Ther. 2001 Jun;3(3):288-94. Curr Opin Mol Ther. 2001. PMID: 11497353 Review.
New treatment options for CMV retinitis in AIDS.
Lalezari JP. Lalezari JP. Adv Nurse Pract. 1997 Apr;5(4):45-9, 83. Adv Nurse Pract. 1997. PMID: 9459896 Review. No abstract available.

See all similar articles

Cited by

Oligonucleotide therapeutics in neurodegenerative diseases.
Scoles DR, Pulst SM. Scoles DR, et al. RNA Biol. 2018;15(6):707-714. doi: 10.1080/15476286.2018.1454812. Epub 2018 Jun 1. RNA Biol. 2018. PMID: 29560813 Free PMC article. Review.
Principle, application and challenges of development siRNA-based therapeutics against bacterial and viral infections: a comprehensive review.
Motamedi H, Ari MM, Alvandi A, Abiri R. Motamedi H, et al. Front Microbiol. 2024 Jun 13;15:1393646. doi: 10.3389/fmicb.2024.1393646. eCollection 2024. Front Microbiol. 2024. PMID: 38939184 Free PMC article. Review.
2'-Deoxy-2'-fluoro-beta-D-arabinonucleosides and oligonucleotides (2'F-ANA): synthesis and physicochemical studies.
Wilds CJ, Damha MJ. Wilds CJ, et al. Nucleic Acids Res. 2000 Sep 15;28(18):3625-35. doi: 10.1093/nar/28.18.3625. Nucleic Acids Res. 2000. PMID: 10982885 Free PMC article.
DNA as therapeutics; an update.
Saraswat P, Soni RR, Bhandari A, Nagori BP. Saraswat P, et al. Indian J Pharm Sci. 2009 Sep;71(5):488-98. doi: 10.4103/0250-474X.58169. Indian J Pharm Sci. 2009. PMID: 20502565 Free PMC article.
Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study.
Patil SD, Rhodes DG. Patil SD, et al. Nucleic Acids Res. 2000 Jun 15;28(12):2439-45. doi: 10.1093/nar/28.12.2439. Nucleic Acids Res. 2000. PMID: 10871378 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information